Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Interventional Cardiology Devices And Equipment Market Expansion Outlook: What Revenue Opportunities Are Ahead?#_x000D_
The market size for interventional cardiology devices and equipment has witnessed substantial growth in recent years. It is projected to increase from $15.65 billion in 2025 to $16.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. Historically, this growth can be attributed to the rising prevalence of cardiovascular diseases, the increased adoption of minimally invasive procedures, the expansion of cardiac catheterization laboratories, improvements in stent and catheter materials, and a growing aging population._x000D_
_x000D_
The interventional cardiology devices and equipment market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $21.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This projected growth can be linked to several factors, including a heightened demand for next-generation interventional devices, the increasing use of AI in cardiac procedures, the broadening scope of outpatient and ambulatory cardiac care, a stronger emphasis on patient-specific therapies, and greater financial commitments to cardiovascular innovation. Key trends expected during this period involve the wider acceptance of drug-eluting and bioabsorbable stents, an increase in sophisticated catheter-based therapies, the growing incorporation of imaging-guided interventions, the proliferation of minimally invasive cardiac procedures, and a stronger commitment to precision and patient safety._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Interventional Cardiology Devices And Equipment Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The expanding prevalence of cardiovascular ailments is projected to drive the expansion of the interventional cardiology devices and equipment market. These conditions encompass health issues impacting the heart, circulatory system, and blood vessels. A significant rise in cardiovascular diseases is attributable to factors such as unhealthy dietary habits, insufficient physical activity, heightened stress, smoking, and obesity. This growing occurrence of cardiovascular diseases is stimulating the need for interventional cardiology devices, as a greater number of cardiac patients require sophisticated instruments for minimally invasive therapeutic interventions, thereby fostering market growth. For example, the Australian Institute of Health and Welfare, an Australia-based government agency, reported in October 2025 that cardiovascular disease represented nearly 12 percent of the overall disease burden in Australia in 2024, specifically 14 percent for males and 10 percent for females. Furthermore, Australians lost an estimated 685,000 years of healthy life, equivalent to 25.5 per 1,000 population, due to various forms of cardiovascular disease. Consequently, the escalation in cardiovascular diseases is set to accelerate the growth of the interventional cardiology devices and equipment market in the coming period._x000D_
_x000D_
#Interventional Cardiology Devices And Equipment Market Segment Analysis And Revenue Potential#_x000D_
The interventional cardiology devices and equipment market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices _x000D_
2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)_x000D_
3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers _x000D_
_x000D_
Subsegments:_x000D_
1) By Angioplasty Balloons: Normal Balloons, Drug-Eluting Balloons, Cutting Balloons _x000D_
2) By Angioplasty Stents: Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), Bioabsorbable Stents _x000D_
3) By Catheters: Guiding Catheters, Balloon Catheters, Angiography Catheters _x000D_
4) By Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices _x000D_
5) By Other Interventional Cardiology Devices: Guidewires, Vascular Closure Devices, Inflation Devices_x000D_
_x000D_
#Interventional Cardiology Devices And Equipment Market Trends Redefining Industry Growth#_x000D_
Leading companies within the interventional cardiology devices and equipment market are prioritizing innovative technological offerings, such as percutaneous transluminal coronary angioplasty (PTCA), to address the rising demand for minimally invasive interventions in cardiovascular disease management. The PTCA dilatation catheter, featuring Twin-Wall technology, provides an advanced solution for effectively treating complex coronary lesions. As an illustration, in February 2023, SIS Medical AG, a medical company situated in Switzerland, unveiled its OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter, which incorporates Twin-Wall technology. This advanced balloon catheter is engineered to deliver enhanced performance specifically in challenging coronary lesions. The OPN NC PTCA catheter has the capacity to improve results for patients afflicted with coronary artery disease._x000D_
_x000D_
#Interventional Cardiology Devices And Equipment Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the interventional cardiology devices and equipment market are GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Cardinal Health Inc., iVascular GmbH, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc. _x000D_
_x000D_
#View The Full Interventional Cardiology Devices And Equipment Market Report:#_x000D_
_x000D_
#Interventional Cardiology Devices And Equipment Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the global interventional cardiology devices and equipment market in 2025. Western Europe was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in the interventional cardiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









